(firstQuint)Dysport In Migraine Without Aura Prophylaxis : DIMWAP Study.

 This is a 12-week, prospective double-blinded, randomized, multicenter study of placebo, 120 Unit, and 240 unit of botulinum toxin A ( Dysport (R) ) injection for patient with a diagnosis of Migraine without aura according to International Headache Society criteria.

 It is designed to evaluate the efficacy, safety, tolerability and optimum dose of Botulinum toxin type A (Dysport (R))injection for migraine without aura prophylaxis.

.

 Dysport In Migraine Without Aura Prophylaxis : DIMWAP Study@highlight

The purpose of this study is to determine whether 120 Unit, and 240 unit of botulinum toxin A are effective in the treatment of migraine without aura prophylaxis.

